Mansouri MH, Mansouri P, Sadeghi M, Hashemi SM, et al. Antianginal effects of empagliflozin in patients with type 2 diabetes and refractory angina; a randomized, double-blind placebo-controlled trial (EMPT-ANGINA Trial). Clin Cardiol 2024;47:e24158.
PMID: 37721420